BeOne Medicines Ltd. (ONC): Shareholders' Equity
$4.36B
As of 2025-12-31
$5.17B
As of 2026-06-30
-0.2%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.36B | +30.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $3.33B | -5.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $3.54B | -19.3% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $4.38B | -28.5% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $6.13B | n/c | 2023-02-27, Balance as of period end |
| 2020-12-31 | $3.87B | +302.1% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $962.21M | -44.7% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $1.74B | +159.7% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $669.81M | +89.8% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $352.91M | n/m | 2018-02-28, Balance as of period end |
| 2015-12-31 | -$101.77M | n/m | 2017-03-22, Balance as of period end |
| 2014-12-31 | -$53.04M | n/a | 2017-03-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗